Reports details

– where will opportunities lie in this diverse market with high, growing demand worldwide?

In 2009, the global pain relieving drug market generated revenues over $50bn. From 2010, that sector will benefit from new drugs and reformulations of existing products. Cases of pain from many conditions are increasing rapidly. Worldwide, the treatment of pain is a priority for healthcare providers, with high demand for drugs. Where is the pain relieving drug market heading - technologically and commercially - from 2010 onwards? 

Our new report - Global Pain Relieving Drug Market Analysis 2010-2025 - explains how this market will develop, and where the opportunities will lie. We show how you can benefit from its developments and potential. There remains unmet therapeutic needs in the treatment of pain. Many conditions have no pain relievers designed for relieving their symptoms, or very few. Side effects and safety constitute a challenge for drug developers. There is also increasing demand for pain treatments in developing countries. Novel compounds that show improved safety – with high efficacy – can gain significant market shares from 2010 onwards. There remain high revenues to be made in this sector from 2010 to 2025, our new report explains how you can benefit from this opportunity.

Global Pain Relieving Drug Market 2010-2025 covers the following therapeutic categories:
• Narcotics for pain
• NSAIDs for pain
• Treatments for arthritic pain
• Treatments for migraine
• Treatments for neuropathic pain
• Local anaesthetics.

What types of therapeutic agents are likely to enter the market from 2010 onwards, and will they dominate? Where do the main opportunities lie, and what are the drivers and restraints in this market? This report will provide you with the information that you need to understand current trends and future directions in the global pain drug market.

Comprehensive analysis of the global pain drug market

Global Pain Relieving Drug Market 2010-2025 examines that sector through a comprehensive review of information sources. We harness both primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of R&D pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are 75 tables and figures included, as well as two original interviews with experts which are unavailable eslewhere. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work.

Why you should buy Global Pain Relieving Drug Market 2010-2025

This report gives you the following benefits in particular:
• You will review the current market for pain-relieving drugs
• You will analyse the overall pain drug market, including a global sales forecast for 2010 to 2025
• You will receive sales forecasts for pain submarkets from 2010 to 2025, with discussions
• You will receive sales forecasts for leading products from 2010 to 2025, with discussions of market potential and competition
• You will receive sales forecasts for leading geographical markets from 2010 to 2025, with discussions
• You will discover prospects for leading companies from 2010 onwards
• You will analyse the drivers, restraints, competition and opportunities influencing the pain drug sector
• You will discover the most-exciting R&D pipeline developments
• You will discover expert views from our survey, including full interview transcripts
• You will investigate under-met needs, with therapeutic requirements and commercial opportunities covered.

You can obtain this report today

Nobody with an interest in the pain relieving drug industry and market should overlook our new study. We predict that total revenues will increase during our forecast period. Rising prevalence of the man

Table Of Contents

Table of Contents
1. Executive Summary
1.1 The Pain Relieving Drug Market: Entering a Crucial Period
1.2 Aims, Scope and Format of the Report
1.3 Research and Analysis Methods

2. Introduction to Pain and its Treatment
2.1 What is Pain?
2.1.1 Historical Aspects of Pain
2.2 Pain Pathways
2.2.1 WHO Pain Ladder
2.3 Classification and Types of Pain
2.3.1 Acute Pain
2.3.2 Chronic Pain
2.3.2.1 Psychosocial Effects of Chronic Pain
2.3.2.2 The Financial Burden of Chronic Pain
2.3.2.3 Chronic Cancer Pain
2.3.2.4 Breakthrough Cancer Pain
2.4 Neuropathic Pain
2.4.1 Distinguishing Neuropathic Pain
2.5 Neurochemistry of Pain
2.5.1 Prostaglandins
2.5.2 Opioids
2.6 Pain Treatments
2.7 OTC Pain Relievers

3. The Global Pain Pharmaceutical Market 2010-2025
3.1 The Global Pain Market: Analysis and Forecast
3.2 Sub-Market Categories of the Global Pain Drug Market
3.2.1 Oxycontin Currently Leads the Global Pain Drug Market
3.2.2 The Anti-Epileptics Segment: Will its Success Last?
3.3 Success in the Pain Relieving Drug Market Has Proved Challenging
3.4 While the Past Has Been Difficult for Pain Management, There is Optimism for the Future

4. The Global Narcotics Market 2010-2025
4.1 The Narcotics Market Analysis and Forecast
4.2 Oxycontin - Therapeutic and Commercial Challenges
4.2.1 Development of Oxycontin (Oxycodone)
4.3 Duragesic (Fentanyl) - Challenges in the Market
4.3.1 Development of Duragesic (Fentanyl)
4.4 Fentanyl MYLA Will Show Strong Revenues
4.4.1 Fentanyl
4.5 Actiq Fighting a Decline in Sales
4.5.1 Actiq (Fentanyl Citrate)
4.6 Other Agents
4.7 Total Sales in the Narcotics Market Will Increase, Despite its Being Crowded

5. The Global Non-Narcotics Market 2010-2025
5.1 The Non-Narcotics Market Analysis and Forecast
5.2 Efferalgan is Currently the Non-Narcotic Market's Leading Drug
5.2.1 Development of Efferalgan (Paracetamol/Acetaminophen)
5.3 Tylenol - a Future Blockbuster of the Non-Narcotics Market?
5.3.1 Development of Tylenol (Paracetamol/Acetaminophen)
5.4 Doliprane (Paracetamol/Acetaminophen)
5.5 Will Advil Exhibit Strong Growth?
5.5.1 Advil (Ibuprofen)
5.6 Aspirin Bayer - Line Extensions Keeping Sales Up
5.6.1 Aspirin Bayer (Acetylsalicylic Acid)
5.7 Other Agents

6. The Global Arthritic Pain Drug Market 2010-2025
6.1 The Arthritic Pain Market Analysis and Forecast
6.1.1 Safety Issues for COX-2 Inhibitors
6.2 Pfizer's Celebrex Dominates the Market, but Will it Last?
6.2.1 Development of Celebrex (Celecoxib)
6.3 Voltaren Will Exhibit Strong Growth
6.3.1 Development of Voltaren (Diclofenac)
6.4 Arcoxia: Strong Growth over the Forecast Period?
6.4.1 Development of Arcoxia (Etoricoxib)
6.5 Loxonin: Sales in Developing Countries Aiding Growth
6.5.1 Loxonin (Loxoprofen)
6.6 Mobic Will Suffer from Generic Competition
6.6.1 Development of Mobic (Meloxicam)
6.7 Other Agents
6.8 Outlook for the Arthritis Pain Drug Market

7. The Global Migraine Market 2010-2025
7.1 The Migraine Drug Market Analysis and Forecast
7.2 GSK's Blockbuster Imitrex/Imigran Faces Revenue Decline
7.2.1 Development of Imitrex/Imigran (Sumatriptan)
7.3 Maxalt's Patent Expiry Will Affect Sales
7.3.1 Development of Maxalt (Rizatriptan)
7.4 Zomig's Decline in Sales
7.4.1 Development of Zomig (Zolmitriptan)
7.5 Relpax Will Exhibit Loss of Revenue from 2010-2025
7.5.1 Development of Relpax (Eletriptan)
7.6 Other Agents
7.7 What Does the Future Hold for Migraine Therapy?
7.8 Unmet Needs in the Treatment of Migraine

8. Neuropathic Pain and Local Anaesthetics Markets 2010-2025
8.1 Introduction
8.1.1 Anti-Epileptic Drugs Market
8.2 Anti-Epileptic Market Analysis and Forecast
8.2.1 Lyrica
8.2.2 The Development of Lyrica (Pregabalin)
8.2.3 Topamax (Topiramate): Impending Patent Expiry

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023 Summary Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • Dec 2014
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.